KFF Health News found records of Abbott payments associated with 10 of the 14 voting members of the FDA advisory panel, which was weighing clinical evidence for a heart device called TriClip G4 ...

If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...

Panel members "praised the promise" of MDMA to ... is "disappointed in the vote" but will continue working with the FDA to meet the "urgent need for new, effective and accessible therapies ...

Nuplazid (pimavanserin) is already FDA-approved to treat psychosis caused by Parkinson's disease, but Acadia's hope to expanding that use to the Alzheimer's population were shot down by a complete ...

Qiagen has received clearance from the US Food and Drug Administration (FDA) for the first in a planned series of gastrointestinal panels for clinical use. For use with the Netherlands-based ...